About Us

Pebble offers a proprietary, state-of-the-art LIVING-ORGAN system to researchers aiming to develop tangible healthcare products and innovations. Line-of-sight to patients is important to us, and sits closely with our strong moral objective to make a difference. We will continually strive to improve our LIVING-ORGAN system models and will bespoke-build systems based on a researcher’s needs – this is often the best part of the job!

We will maintain our strong 3R’s ethos (Reduction, Refinement and Replacement of small animals in research), and offer an ethical alternative to large animal research. Our approach guarantees that no laboratory animals are used. Instead, we support local farmers in rearing pigs to the highest husbandry standards, using only surplus biological material. This is important, not only ethically, but also to ensure that we have full provenance of our biological material. 

Our Ethos

We are a high knowledge and innovative company. Inherently, we are developing our own products and therapies across three business units. Our pipeline includes a broad range of perfusion and preservation solutions, protocols and systems, and first-in-class blood purification systems for leukocytes, cytokines, complement components and electrolytes. 

Our Pipeline

The Management Board

CEO & Chief Scientist

Prof James Fildes

Mark Claydon

COO

Non-Executive Director

Doug Stellman

CFO

Richard Smith

Non-Executive Director

Les Russell

Non-Executive Director

Michael Nation

Laboratory Operations Director

John Stone

The Scientists

CSO

Prof James Fildes

Principal Scientist

Dr Tim Entwistle

Principal Scientist

Dr John Stone

Academic Surgeon

Mr Kavit Amin

William Cowey

Research Scientist

Amy Stewart

Research Scientist

Research Scientist

Cara Brown

Research Scientist

Corban Bowers

Research Technician

Research Technician

Poppy Hearne

Research Technician

Georgie Chesworth

Research Technician

Katie Ogden

Eliza Stokoe